- Poster presentation
- Open access
- Published:
Mastermind-like 1 (MAML-1) as a new metastatic marker in esophageal squamous cell carcinoma
BMC Proceedings volume 4, Article number: P3 (2010)
Deregulation of the normal cellular processes that mediate cell proliferation, differentiation and death programs, have been seeing in various tumor cell types [1]. Notch signaling pathway that plays fundamental roles in definition of the cell fate and self-renewal is frequently deregulated in human malignancies, by up or down regulation, where it may act either as an oncogene or as a tumor suppressor depending on the cell context [2, 3]. The MAML proteins are transcriptional co-activators of notch signalling that are not only essential for related responses, but also have some regulatory functions in other signaling pathways, including p53 and Wnt/beta-catenin, and therefore have a central role in signaling cross talk of diverse cellular processes such as cell proliferation, differentiation and survival [4].
In current study, the expression of MAML-1 and EGFR genes were analyzed in 44 esophageal squamous cell carcinoma (ESCC) patients with the quantitative (real-time) RT-PCR. Overexpression of these genes was found in 45.5% and 38.6% of ESCC samples respectively. Relative expression of MAML-1 was significantly associated with the lymph node metastasis of tumor cells (P < 0.05).
Since MAML-1 is an essential transcription coactivator of notch signaling pathway and downstream related genes expression, we extrapolated that, notch signaling may contribute in tumor development and metastasis in ESCC, however further studies are required. We report for the first time that MAML-1 gene is overexpressed as a metastasis-related gene in ESCC samples. This indicates that MAML-1 may be a possible metastatic marker of ESCC and a possible good therapeutic target in order to block tumor cell metastasis.
References
Allenspach EJ, Maillard I, Aster JC, Pear WS: Notch signaling in cancer. Cancer Biol Ther. 2002, 1: 466-476. 10.4161/cbt.1.5.162.
Koch U, Radtke F: Notch and cancer: a double-edged sword. Cell Mol Life Sci. 2007, 64: 2746-2762. 10.1007/s00018-007-7164-1.
Bolós V, Grego-Bessa J, de la Pompa JL: Notch signaling in development and cancer. Endocr Rev. 2007, 28: 339-363. 10.1210/er.2006-0046.
McElhinny AS, Li J-L, Wu L: Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways. Oncogene. 2008, 27: 5138-5147. 10.1038/onc.2008.228.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Forghanifard, M.M., Farshchian, M., Raeisossadati, R. et al. Mastermind-like 1 (MAML-1) as a new metastatic marker in esophageal squamous cell carcinoma. BMC Proc 4 (Suppl 2), P3 (2010). https://doi.org/10.1186/1753-6561-4-S2-P3
Published:
DOI: https://doi.org/10.1186/1753-6561-4-S2-P3